Registry Shows 63% Response Rate to TNF Inhibitor in AS

COPENHAGEN â€" Treatment with a tumor necrosis factor inhibitor produced a 63% clinical response rate in 842 ankylosing spondylitis patients who were treated for a median of more than a year in Denmark.